Adjunctive high-dose glycine in the treatment of schizophrenia.
Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR.
Javitt DC, et al. Among authors: shelley am.
Int J Neuropsychopharmacol. 2001 Dec;4(4):385-91. doi: 10.1017/S1461145701002590.
Int J Neuropsychopharmacol. 2001.
PMID: 11806864
Free article.
Clinical Trial.